These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 10624064)
1. Diet and coronary artery disease. Krishnamoorthy KM Indian Heart J; 1999; 51(3):268-74. PubMed ID: 10624064 [No Abstract] [Full Text] [Related]
2. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components. Ghafoorunissa Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688 [TBL] [Abstract][Full Text] [Related]
3. Iron status and the risk of coronary heart disease. Sempos CT; Looker AC Nutr Metab Cardiovasc Dis; 1999 Dec; 9(6):294-303. PubMed ID: 10765522 [No Abstract] [Full Text] [Related]
7. [Cholesterol. A review of the new directives]. Becker DM; Larosa JH; Watson JE Servir; 1990; 38(6):283-6. PubMed ID: 2291108 [No Abstract] [Full Text] [Related]
8. Preventive strategies for reducing coronary heart disease-related morbidity and mortality in patients with multiple risk factors. Brown WV J Am Osteopath Assoc; 2001 Sep; 101(9 Suppl):S6-11. PubMed ID: 11575043 [TBL] [Abstract][Full Text] [Related]
9. Introduction: missing the target with lipid-lowering therapy. Hunninghake DB; McKenney JM Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370 [No Abstract] [Full Text] [Related]
10. Profile of coronary artery disease in vegetarian community. Jhatakia KU Indian Heart J; 1973 Apr; 25(2):94-9. PubMed ID: 4726269 [No Abstract] [Full Text] [Related]
11. Effects of two lipid-lowering, carotenoid-controlled diets on the oxidative modification of low-density lipoproteins in free-living humans. Ahuja KD; Ashton EL; Ball MJ Clin Sci (Lond); 2003 Sep; 105(3):355-61. PubMed ID: 12780345 [TBL] [Abstract][Full Text] [Related]
12. Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment. Davidson MH Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1582-3. PubMed ID: 18716322 [No Abstract] [Full Text] [Related]
13. Dyslipidemia and coronary heart disease: management issues from Indian perspective. Gambhir DS; Gambhir JK; Sudha R Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772 [No Abstract] [Full Text] [Related]
15. Reverse cholestrol transport substantially influences the individual risk of coronary heart disease in hypercholesterolaemic patients. Poledne R; Rosolová H Eur Heart J; 2001 Mar; 22(6):442-3. PubMed ID: 11237535 [No Abstract] [Full Text] [Related]
16. Evaluation and treatment of lipid disorders in women. Zelis R Curr Womens Health Rep; 2003 Apr; 3(2):97-103. PubMed ID: 12628078 [TBL] [Abstract][Full Text] [Related]
17. Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals. Loktionov A; Scollen S; McKeown N; Bingham SA Br J Nutr; 2000 Dec; 84(6):885-90. PubMed ID: 11177205 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of hyperlipidemia]. Yoshino G Rinsho Byori; 2002 Mar; 50(3):254-61. PubMed ID: 11985052 [TBL] [Abstract][Full Text] [Related]
19. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)? Sherrod JP; Krist A J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006 [No Abstract] [Full Text] [Related]
20. Commentary: Geoffrey Rose's thinking about coronary artery disease. Faergeman O Int J Epidemiol; 2005 Apr; 34(2):246-7. PubMed ID: 15764696 [No Abstract] [Full Text] [Related] [Next] [New Search]